CYTOSORBENTS MEDICAL INC
Princeton, NJ · Medtech · Public
Immunoadsorption cartridge device that removes inflammatory mediators from blood to treat joint injuries and inflammation
cytosorbents.com →- Grants
- $10M
- 12 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- $17M
- 9 awards · Defense, Health and Human S
- #47 of 4531 in medtech
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2011201320152017201920212023
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal contract | Department of Defense · SBIR Phase I - (A112-105-0585) | $1,246,262 | |
| Federal contract | Department of Defense · R&d Services Iaw The Sow | $3,825,142 | |
| Federal contract | Department of Health and Human Services · Igf::ot::igf Develop A Hemocompatible, Easy-to-use, Cost-effective Blood Purification System To Effectively Wash Blood Of A Broad Range Of Contaminants Without The Expense, Logistics, And Time Currently Required To Physically Wash Blood. The Removal Of Reactive Species Of Hemolysis, Oxidants And Red Cell Microvesicles From Blood May Also Potentially Reduce Injury To Erythrocytes And Reduce Blood Storage Lesions. The Beads Can Be Utilized In Two Treatment Configurations: 1) A Beads-in-a-bag, In | $203,351 | |
| Federal contract | Department of Health and Human Services · Igf::ot::igf To Develop Hemodefend, Hemocompatible, Highly Porous Polymer Beads Optimized To Broadly Remove Freehemoglobin, Potassium, Reactive Antibodies, And Inflammatory Or Reactive Substances From Blood Based On A Provenpore Capture And Surface Adsorption Technology Platform. | $1,524,173 | |
| Federal grant | Department of Defense · Phase I · Mycotoxin Adsorption with Hemocompatible Porous Polymer Beads | $149,936 | |
| Federal contract | Department of Defense · Igf::ot::igf | $9,000 | |
| Federal grant | Department of Defense · Phase I · Use of Highly Porous Polymer Beads to Remove Anti-A and Anti-B Antibodies from Plasma for Transfusion | $149,979 | |
| Federal grant | Department of Defense · Phase I · Investigation of a sorbent-based potassium adsorber for the treatment of hyperkalemia induced by traumatic injury and acute kidney injury in austere medicine | $149,927 | |
| Federal grant | Department of Defense · Phase II · Mycotoxin Adsorption with Hemocompatible Porous Polymer Beads | $999,997 | |
| Federal grant | Department of Defense · Phase II · Use of Highly Porous Polymer Beads to Remove Anti-A and Anti-B Antibodies from Plasma for Transfusion | $999,070 | |
| Federal grant | Department of Defense · Phase II · Investigation of a sorbent-based potassium adsorber for the treatment of hyperkalemia induced by traumatic injury and acute kidney injury in austere medicine | $999,871 | |
| Federal grant | Department of Health and Human Services · Phase II · pRBC Contaminant Removal with Hemocompatible Porous Polymer Beads | $2,970,974 | |
| Federal contract | Department of Defense · K+ontrol Renal Support System For Reduction Of Hyperkalemia - Rif | $2,849,920 | |
| Federal contract | Department of Defense · Award Of Cytosorbents' Dha STTR Rif Phase III Medical R&d Contract From Proposal DHP15B-001-P-6144 For "development Of A Highly Efficient Adsorber To Remove Anti-a And Anti-b Antibodies From Blood And Plasma For Transfusion" | $2,897,172 | |
| Federal grant | Department of Defense · Phase II · Development of an Effective Adsorber to Remove Anti-A and Anti-B Antibodies from Plasma for Transfusion | $1,098,589 | |
| Federal grant | Department of Defense · Phase II · Investigation of a potassium adsorber for the treatment of hyperkalemia induced by traumatic injury and acute kidney injury in austere medicine | $1,499,987 | |
| Federal contract | Department of Defense · Award Of Cytosorbents Dha SBIR Ph III Med R&d Contract For "integrating Isoagglutinin Reduction For A Universal Dried Plasma Product For Battlefield And First Responder Use" | $4,292,641 | |
| Federal grant | Department of Health and Human Services · Phase I · Novel Extracorporeal Therapy for the Reversal of Septic Shock and Restoring Hemodynamic Stability | $288,335 | |
| Federal contract | Department of Defense · Novel Oral Sorbent Therapy For The Prevention And Treatment Of Travelers Diarrhea | $74,955 | |
| Federal grant | Department of Defense · Phase I · Novel Sorbent Technology for the Rapid Treatment of Acute Joint Injury and Inflammation | $74,918 |
Federal grant · SBIR/STTRFederal contract · USAspending
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 44 | Nanostring Technologies | $18M | $52M |
| 45 | ADVANCED BRAIN MONITORING, INC. | $18M | $837K |
| 46 | CareDx, Inc. | $17M | $22M |
| 47 | CYTOSORBENTS MEDICAL INC | $17M | — |
| 48 | INDEVR, INC | $16M | $10.0M |
| 49 | WOLF TECHNICAL SERVICES INC | $16M | — |
| 50 | Nevro Corp | $14M | $79M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.